ClinicalTrials.Veeva

Menu

Feasibility Study of Sentinel Navigation Surgery After Non-curative Endoscopic Resection (SENORITA2)

N

National Cancer Center (NCC)

Status

Completed

Conditions

Early Gastric Cancer
Sentinel Lymph Node

Treatments

Procedure: Sentinel basin dissection

Study type

Interventional

Funder types

Other

Identifiers

NCT03123042
1710162

Details and patient eligibility

About

Purpose: To prove the feasibility of sentinel node navigation surgery (SNNS) in early gastric cancer patients with the risk of lymph node metastasis after endoscopic resection and preparation of multicenter phase 3 trial of stomach preserving surgery in these patients.

Contents: The number of enrollment is 247 patients. The patients underwent endoscopic resection for early gastric cancer, and the tumor was defined to be out of indication for endoscopic resection pathologically. So, additional gastrectomy is recommended for them.

The investigators will enroll patients who agree this study. After general anesthesia, Tc99m-Phytate with indocyanine green will be injected with endoscopy. Then sentinel basin will be detected using gamma probe and laparoscopic basin dissection will be done. Sentinel lymph node will be identify in back table dissection, and patients will undergo conventional gastrectomy. Detection rate and false negative rate will be evaluated by pathological review.

Full description

Sentinel basin dissection method

  1. endoscopic tracer injection after general anesthesia
  2. Tracer : Tc99m-phytate 3cc and indocyanine green 3cc mix --> Injection of the probe (1cc/site, 4 sites) around endoscopic submucosal dissection ulcer scar
  3. Sentinel basin identification with laparoscopic probe
  4. Dissection of the sentinel basin
  5. Sentinel node dissection at back table
  6. Conventional laparoscopic gastrectomy

Enrollment

243 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • No limitation for age if the patient is available for gastrectomy
  • Patient who underwent endoscopic submucosal dissection and the tumor was defined as out of indication.

The expanded criteria for endoscopic resection are as follows

  • criterion I: intramucosal tumor without ulcerative findings and of differentiated type with size > 2 cm
  • criterion II: intramucosal tumor with ulcerative findings and of differentiated type with size ≤ 3 cm
  • criterion III: intramucosal tumor without ulcerative findings and of undifferentiated type with size < 2 cm
  • criterion IV, submucosal invasion < 500 mm and of differentiated type with size ≤ 3 cm)
  • Eastern Cooperative Oncology Group (ECOG) performance scale 0 or 1

Exclusion criteria

  • Inoperative due to severe cardiovascular or pulmonary disease
  • Pregnant
  • Patients who had previous gastric surgery
  • Patients who had previous upper abdomen surgery except cholecystectomy, or radiation therapy on upper abdomen, or hypersensitivity to any medicine

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

243 participants in 1 patient group

Sentinel basin dissection
Experimental group
Description:
Intervention: Sentinel basin dissection
Treatment:
Procedure: Sentinel basin dissection

Trial contacts and locations

9

Loading...

Central trial contact

Bang Wool Eom, MD, PhD; Keun Won Ryu, MD.PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems